(Q45886414)

17 December 2017

title

Serum protein profile of Crohn's disease treated with infliximab (English)

1 reference

17 December 2017

1 reference

Maria Gazouli

1

1 reference

17 December 2017

Athanasios K Anagnostopoulos

2

1 reference

17 December 2017

Aggeliki Papadopoulou

3

1 reference

17 December 2017

Anna Vaiopoulou

4

1 reference

17 December 2017

Konstantinos Papamichael

5

1 reference

17 December 2017

Gerassimos Mantzaris

6

1 reference

17 December 2017

George E Theodoropoulos

7

1 reference

17 December 2017

Nicholas P Anagnou

8

1 reference

17 December 2017

George Th Tsangaris

9

1 reference

17 December 2017

publication date

3 April 2013

1 reference

17 December 2017

Journal of Crohn's and Colitis

published in

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

e461-70

1 reference

17 December 2017

Inflammatory Bowel Disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Etiology of Crohn's disease: many roads lead to autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

The genetics and immunopathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

GWA studies: rewriting the story of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

The biological impact of mass-spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Mining the plasma proteome for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Current advantages in the application of proteomics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Assessing response and loss of response to biological therapies in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Potential biomarkers for Turner in maternal plasma: possibility for noninvasive prenatal diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Quantitation of apolipoprotein epsilon gene expression by competitive polymerase chain reaction in a patient with familial apolipoprotein E deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

TNFalpha blockade in human diseases: mechanisms and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Role of cytokines in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Proteomic analysis of circulating immune complexes in juvenile idiopathic arthritis reveals disease-associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

STRING 8--a global view on proteins and their functional interactions in 630 organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.02.021

10.1016/J.CROHNS.2013.02.021

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017